Foam embolic protection device

Information

  • Patent Grant
  • 8152831
  • Patent Number
    8,152,831
  • Date Filed
    Thursday, November 16, 2006
    18 years ago
  • Date Issued
    Tuesday, April 10, 2012
    12 years ago
Abstract
An embolic protection device includes a foam body attached to a plurality of flexible struts. The foam body has a generally conical geometry and the bottom of the conical geometry having a generally conical recess. The filter portion has pores sized such that blood cells can pass through the foam body, but larger material such as objects would be trapped in the recess. Each strut is attached along the periphery of the foam body and extend from the first end of the foam body to a connection point located proximate the first end.
Description
BACKGROUND

1. Field of the Invention


The present invention generally relates to a medical device for embolic protection.


2. Description of Related Art


With the continuing advance of medical techniques, interventional procedures are more commonly being used to actively treat stenosis, occlusions, lesions, or other defects within a patient's blood vessels. Often the treated regions are in the coronary, carotid or even cerebral arteries. One procedure for treating an occluded or stenosed blood vessel is angioplasty. During angioplasty, an inflatable balloon is introduced into the occluded region. The balloon is inflated, pushing against the plaque or other material of the stenosed region and increasing the intralumenal diameter of the vessel. As the balloon presses against the material, portions of the material may inadvertently break free from the plaque deposit. These emboli may travel along the vessel and become trapped in a smaller blood vessel restricting blood flow to a vital organ, such as the brain.


Other methods for removing plaque or thrombus from arteries may include mechanical ablation, or non-contact ablation using light waves, sound waves, ultrasonics, or other radiation. Each of these methods are subject to the risk that some thrombogenic material may dislodge from the wall of the vessel and occlude a smaller blood vessel. The occlusion may cause damage to the patient, including an ischemic stroke in the cerebral arteries.


To prevent the risk of damage from emboli, many devices have been used to restrict the flow of emboli downstream from the stenosed area. One method includes inserting a balloon that may be expanded to occlude the flow of blood through the artery downstream of the stenosed area. An aspirating catheter may be located between the balloon and stenosed area and used to remove emboli that may be caused by the treatment. However, because the balloon completely blocks blood flow through the vessel, the vessel may be occluded only for short periods of time, limiting use of the procedure.


As an alternative to occluding flow through the blood vessel, various filtering devices have been proposed. Such devices typically have elements that form legs or a mesh that capture embolic material, but allow blood cells to flow between the elements. Capturing the emboli in the filter device prevents the material from being lodged downstream in a smaller blood vessel. The filter may then be removed along with the embolic material after the procedure has been performed and the risk from emboli has decreased.


Challenges also exist with filtering devices. Often it is desirable to deploy filter devices from the proximal side of a stenosis. Therefore, the profile of the filtering device should be smaller than the opening in the stenosed vessel. Further, the smaller the profile of the filtering device the less risk of dislodging emboli during deployment of the device. In addition, if the filter portion is not held against the inside of the vessel wall, there is a risk that embolic material may pass between the filter and the vessel wall. The filter portion should also be durable and firmly secured to the medical device, since any damage caused to the medical device during deployment increases the risk that emboli might breach the medical device.


In view of the above, it is apparent that there exists a need for an improved medical device for embolic protection.


SUMMARY

In satisfying the above need, as well as overcoming the enumerated drawbacks and other limitations of the related art, the present invention provides an improved medical device for embolic protection.


The embolic protection device includes a foam body attached to a plurality of flexible struts. The foam body has a generally conical geometry and the bottom of the conical geometry includes a generally conical recess. The filter portion has pores sized such that blood cells can pass through the foam body, but larger material such as emboli are trapped in the recess. Each strut is attached along the periphery of the foam body and extend from the first end of the foam body to a connection point located proximate the first end. The struts are attached to one another to form a cannula extending proximally from the filter portion.


The struts are biased into an expanded state such that the filter portion is forced against an inner wall of the vessel. The embolic protection device also includes a core wire extending between the first and second ends of the basket. The core wire may be moved relative to the struts forcing the basket into a collapsed state.


Folds are provided in the filter portion to facilitate insertion and removal of the medical device. The folds extend radially from the apex along the side of the conical shape. The folds form an accordion-like alternating pattern of periodically spaced inward and outward folds.


Further objects, features and advantages of this invention will become readily apparent to persons skilled in the art after a review of the following description, with reference to the drawings and claims that are appended to and form a part of this specification.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1 is a side view of a medical device in accordance with the present invention;



FIG. 2 is an perspective view of the medical device in FIG. 1;



FIG. 3
a is a side view of an embolic protection assembly for capturing emboli during treatment of a stenotic lesion in accordance with one embodiment of the present invention;



FIG. 3
b is an exploded side view of the assembly in FIG. 3a;



FIG. 4 is a sectional view of a blood vessel illustrating insertion of the medical device of FIG. 1 in the collapsed state;



FIG. 5 is a sectional view of the blood vessel illustrating the medical device of FIG. 1 in a fully deployed state;



FIG. 6 is a sectional view of the blood vessel illustrating removal of the medical device from the vessel;



FIG. 7 is a side view of another embodiment of the present invention including a floppy tip;



FIG. 8 is a side view of yet another embodiment of the present invention including a guide wire adapter.





DETAILED DESCRIPTION

Referring now to FIGS. 1 and 2, the medical device 10 includes a basket 12 formed from a filter portion 14 and a plurality of struts 16. The filter portion 14 has a foam body that forms a generally conical geometry. A conical recess 26 is provided in the bottom of the conical geometry allowing fluid and emboli to be contained within the recess 26. The opening 25 of recess 26 is enlarged when the basket 12 is in the expanded state for capturing emboli. As such, the opening 25 and recess 26 are configured to face toward the stenotic lesion. Accordingly, the filter portion 14 forms a proximally facing concave shape. The foam body is porous such that blood cells may be allowed to permeate and flow through the filter portion 14, while larger material such as emboli would be trapped within the recess 26. Accordingly, the size of the pores may be between about 80 and 100 micrometers, thereby allowing objects the size of blood cells to traverse through the pores.


The foam body may be made of any polymeric material, metal, shape memory alloy, mixtures thereof, or any suitable material to be used for capturing emboli from the stenotic lesion during treatment thereof without falling beyond the scope or spirit of the present invention. Preferably, the foam body is comprised of a shape memory material. More preferably, the foam body is comprised of a porous Nitinol foam. As described in more detail below, the super elastic and shape memory characteristics will facilitate the expansion and collapse of the filter portion 14 as the medical device 10 is deployed or retrieved.


A plurality of folds 28 are also formed in the filter portion 14. The folds 28 extend radially from the apex of the conical geometry and along the sides of the conical geometry. The folds 28 include a plurality of inward and outward folds in an alternating pattern. One example, of an alternating pattern of inward and outward folds is often illustrated by an accordion. The folds 28 minimize the profile of the foam body when it assumes the collapsed state. As previously discussed, minimizing the profile of the medical device 10 reduces the risk of dislodging emboli during insertion of the medical device 10.


The struts 16 are attached to the second end of the filter portion 14 and are radially spaced about the opening 25 in the bottom of the conical geometry. The struts 16 may be attached to the filter portion 14 by any suitable means, including but not limited to sonic bonding, thermal bonding, or adhesive bonding. The struts 16 extend proximally from the second end of the filter portion 14 and are attached to one another at a point proximate and concentrically aligned with the conical geometry. The struts 16 cooperate to form a tubular portion 15 that further extends proximally relative to the filter portion 14. A core wire 24 runs through the basket 12 and extends to the apex of the conical geometry. The tubular portion 15 includes a lumen that slidably engages the core wire 24. The struts 16 and core wire 24 may be used to facilitate the transition of the filter portion 14 between an expanded state and a collapsed state.


The struts 16 may be comprised of any suitable material, for example a superelastic material such as Nitinol, stainless steel wire, cobalt-chromium-nickel-molybdenum-iron alloy, or cobalt-chrome alloy. It is understood that the struts 16 may be formed of any other suitable material that will result in a self-opening or self-expanding basket, such as shape memory alloys. Shape memory alloys have the desirable property of becoming rigid, that is, returning to a remembered state, when heated above a transition temperature. A shape memory alloy suitable for the present invention is Ni—Ti available under the more commonly known name Nitinol. When this material is heated above the transition temperature, the material undergoes a phase transformation from martensite to austenite, such that material returns to its remembered state. The transition temperature is dependent on the relative proportions of the alloying elements Ni and Ti and the optional inclusion of alloying additives.


In one embodiment, the struts 16 and filter portion 14 are made from Nitinol with a transition temperature that is slightly below normal body temperature of humans, which is about 98.6° F. Although not necessarily a preferred embodiment, when the basket 12 is deployed in a body vessel and exposed to normal body temperature, the alloy of the struts 16 and filter portion 14 will transform to austenite, that is, the remembered state, which for one embodiment of the present invention is the expanded configuration when the basket 12 is deployed in the body vessel. To facilitate removal of the basket 12, the struts 16 and filter portion 14 are cooled to transform the material to martensite which is more ductile than austenite, making the struts 16 and filter portion 14 more malleable. As such, the basket 12 can be more easily collapsed and pulled into a lumen of a catheter for removal.


In another alternate embodiment, the struts 16 and filter portion 14 are made from Nitinol with a transition temperature that is above normal body temperature of humans, which is about 98.6° F. Although not necessarily a preferred embodiment, when the basket 12 is deployed in a body vessel and exposed to normal body temperature, the struts 16 and filter portion 14 are in the martensitic state so that the basket 12 is sufficiently ductile to bend or form into a desired shape, which for the present invention is an expanded configuration. To facilitate removal of the basket 12, the struts 16 and filter portion 14 are heated to transform the alloy to austenite so that the basket 12 becomes rigid and returns to a remembered state, which for the basket 12 of this alternate embodiment is a collapsed configuration.


In one embodiment of the medical device 10, the core wire 24 extends from the tubular portion 15 and is attached to the filter portion 14 at the apex of the conical geometry. The struts 16 and filter portion 14 are biased into an expanded state providing a radial force to support the filter portion 14 against an inner wall of the vessel. Accordingly, the core wire 24 may be moved distally relative to the struts 16, such that the struts 16 will be pulled tight against the core wire 24 causing the filter portion 14 to collapse along the pattern of alternating inward and outward folds 28 in the foam body. Drawing the filter portion 14 tightly against the core wire 24, minimizes the diameter of the medical device 10 for insertion. As previously discussed, minimizing the profile of the medical device 10 during insertion reduces the risk of dislodging emboli as the medical device 10 is inserted.


In use, the device 10 expands from the collapsed state to the expanded state, engaging the body vessel with the filter portion 14. In turn, the filter portion 14 expands to open the recess 26 in the conical geometry for capturing emboli during treatment of the stenotic lesion. After the need for such device 10 in the vasculature passes, the device 10 may be retrieved.



FIGS. 3
a and 3b depict an embolic protection assembly 40 for capturing emboli during treatment of a stenotic lesion in a body vessel in accordance with another embodiment of the present invention. As shown, the assembly 40 comprises a balloon catheter 42 having a tubular body 44 and an expandable balloon 46 attached to and in fluid communication with the tubular body 44 for angioplasty at a stenotic lesion. In this embodiment, the assembly 40 comprises the embolic protection device mentioned above. The tubular body 44 is preferably made of soft flexible material such as silicon or any other suitable material. In this embodiment, the balloon catheter 42 includes an outer lumen and an inner lumen. The outer lumen is in fluid communication with the balloon 46 for inflating and deflating the balloon 46. The inner lumen is formed therethrough for percutaneous guidance through the body vessel.


As shown, the assembly 40 further includes an inner catheter 52 having a distal end 54 through which the balloon catheter 42 is disposed for deployment in the body vessel. The inner catheter 52 is preferably made of a soft, flexible material such as silicon or any other suitable material. Generally, the inner catheter 52 further has a proximal end 56 and a plastic adaptor or hub 58 to receive the embolic protection device and balloon catheter 42 to be advanced therethrough. The size of the inner catheter 52 is based on the size of the body vessel in which it percutaneously inserts, and the size of the balloon catheter 42.


As shown, the assembly 40 may also include a wire guide 60 configured to be percutaneously inserted within the vasculature to guide the inner catheter 52 to a location adjacent a stenotic lesion. The wire guide 60 provides the inner catheter 52 (and balloon catheter 42) a path during insertion within the body vessel. The size of the wire guide 60 is based on the inside diameter of the inner catheter 52.


In one embodiment, the balloon catheter 42 has a proximal fluid hub 62 in fluid communication with the balloon 46 via the outer lumen for fluid to be passed therethrough for inflation and deflation of the balloon 46 during treatment of the stenotic lesion.


As shown, the embolic protection device is coaxially disposed through the inner lumen of the balloon catheter 42 prior to treatment of the stenotic lesion in the body vessel. The distal protection device is guided through the inner lumen preferably from the hub 58 and distally beyond the balloon 46 of the balloon catheter 42, exiting from the distal end of the inner or balloon catheter 42 to a location within the vasculature downstream of the stenotic lesion.


In this embodiment, the apparatus further includes a polytetrafluoroethylene (PTFE) introducer sheath 64 for percutaneously introducing the wire guide 60 and the inner catheter 52 in a body vessel. Of course, any other suitable material may be used without falling beyond the scope or spirit of the present invention. The introducer sheath 64 may have any suitable size, e.g., between about three-french to eight-french. The introducer serves to allow the inner and balloon catheters 42 to be percutaneously inserted to a desired location in the body vessel. The introducer sheath 64 receives the inner catheter 52 and provides stability to the inner catheter at a desired location of the body vessel. For example, the introducer sheath 64 is held stationary within a common visceral artery, and adds stability to the inner catheter 52, as the inner catheter 52 is advanced through the introducer sheath 64 to a dilatation area in the vasculature.


When the distal end 54 of the inner catheter 52 is at a location downstream of the dilatation area in the body vessel, the balloon catheter 42 is inserted therethrough to the dilatation area. The device 10 is then loaded at the proximal end of the balloon catheter 42 and is advanced through the inner lumen thereof for deployment through its distal end. In this embodiment, the proximal stem is used to mechanically advance or push the device 10 through the catheter.


Now referring to FIG. 4, a cutaway view of a vessel 70 is provided illustrating insertion of the medical device 10. The medical device 10 is inserted with the basket 12 in a collapsed state, allowing the medical device 10 to navigate through the narrow opening formed by the stenosed area 72. Accordingly, during insertion, the profile of the medical device 10 should be minimized. As such, the core wire 24 is moved distally relative to the struts 16 drawing the struts 16 and the filter portion 14 tightly against the core wire 24, thereby forming a collapsed state. The medical device 10 is inserted into the vessel 70 past the stenosis 72 as denoted by the distally pointing arrow 74.


Once the basket portion 12 of the medical device 10 is located distal the stenosis 72, the basket portion 12 can be expanded against the inner wall of the blood vessel 70 as shown in FIG. 5. As previously discussed, the filter portion 14 may also be made of a shape memory material such that the filter portion 14 has two defined geometries. For example, the mesh material may be made of a shape memory alloy so that the foam body is biased into a collapsed state at a first temperature. The first temperature being controlled, for example, by fluid flowing through a guiding catheter 16 across the medical device 10. At a second temperature, such as the ambient temperature inside the vessel 70, the filter portion 14 is biased into a proximally facing concave geometry.


In the expanded state, the struts 16 and filter portion 14 provide a radial force against the inner wall of the vessel 70. The radial force eliminates gaps between the filter portion 14 and the vessel 70 forcing embolic material that is released from the stenosis 72 to be trapped downstream in the recess 26 of the filter portion 14. After a procedure is performed on the stenosis 72, the core wire 24 is moved distally relative to the struts 16 to collapse the struts 16 and filter portion 14 tightly against the core wire 24, as shown in FIG. 6. In the collapsed state, the emboli are trapped within the filter portion 14 and a catheter is slid over the medical device 10. The medical device 10 in the collapsed state, may then be removed proximally as denoted by proximally pointing arrow 76.


Now referring to FIG. 7, the medical device 10 may include a floppy tip 80 located distal the second end 20 of the basket 12 to provide additional guidance during insertion. The floppy tip 80 may extend from the second end 20 and may include a hydrophilic or other lubricious coating to facilitate easy advancement of the medical device to and through the stenosed region of the blood vessel during insertion. The floppy tip 80 is attached to the second end 20, for example by adhesive bonding, and may be made of nylon, polymeric material, silicone, Teflon, or other commonly known material without falling beyond the scope or spirit of the present invention. The flexibility provided by the floppy tip 80, aids in advancement of the medical device through the vessel while minimizing any trauma caused during the advancement.


Now referring to FIG. 8, another embodiment of a medical device in accordance with the present invention is provided. A tubular member 90 may be located on a tip 92 or in lieu of the tip extending distally from the second end 20 of the basket portion 12. The tubular member 90 may be made of nylon, polymeric material, Teflon, superelastic metal or other commonly known material without falling beyond the scope or spirit of the present invention. The tubular member 90 may include a first opening 94 and a second opening 96 such that a wire guide 98 may extend through the first and second opening 94, 96 of the tubular member 90. Accordingly, the tubular member 90 allows the medical device 10 to be guided along the wire guide 98 or alternatively allowing the wire guide 98 to be advanced together with the medical device 10 during insertion.


As a person skilled in the art will readily appreciate, the above description is meant as an illustration of implementation of the principles this invention. This description is not intended to limit the scope or application of this invention in that the invention is susceptible to modification, variation and change, without departing from spirit of this invention, as defined in the following claims.

Claims
  • 1. An embolic protection device for use in a vessel, the embolic protection device comprising: a filter portion including a porous foam body comprised of a shape memory alloy foam, pores of the porous foam body being sized to allow blood to flow through the foam body; anda plurality of struts attached to the filter portion and extending proximally therefrom, the filter portion and the plurality of struts forming a basket, where the basket is configured to have an expanded and collapsed state;wherein the foam body has a generally conical geometry and wherein the struts are radially spaced around the circumference of the generally conical geometry; and a plurality of folds in the generally conical geometry, each fold extending radially from an apex of the generally conical geometry and along a side of the generally conical geometry.
  • 2. The embolic protection device according to claim 1, wherein the filter portion is comprised of a Nitinol foam.
  • 3. The embolic protection device according to claim 1, further comprising a core wire attached to a distal end of the filter portion and extending proximally through the basket.
  • 4. The embolic protection device according to claim 1, wherein the basket is biased into an expanded state.
  • 5. The embolic protection device according to claim 1, wherein the filter portion includes a recess configured to trap emboli.
  • 6. The embolic protection device according to claim 1, wherein the plurality of folds form an alternating pattern of inward and outward folds periodically spaced around a circumference of the generally conical geometry.
  • 7. The embolic protection device according to claim 1, further comprising a floppy tip attached to the distal end of the basket.
  • 8. The embolic protection device according to claim 1, further comprising a tubular portion attached to the distal end of the basket, the tubular portion being configured to receive a wire guide through the tubular portion.
  • 9. An embolic protection device according to claim 1, wherein the pores are between about 80 and 100 micrometers.
  • 10. An embolic protection device for use in a vessel, the embolic protection device comprising: a filter portion including a porous Nitinol foam body having a conical geometry, pores of the porous Nitinol foam body being sized to allow blood to flow through the foam body;a plurality of struts attached to the filter portion and extending proximally therefrom, the filter portion and the plurality of struts forming a basket, where the basket is configured to have an expanded and collapsed state; anda plurality of folds in the conical geometry, the plurality of folds extending radially from an apex of the conical geometry and along a side of the conical geometry, wherein the plurality of folds form an alternating pattern of inward and outward folds periodically spaced around a circumference of the conical geometry.
  • 11. The embolic protection device according to claim 10, wherein the basket is biased into an expanded state.
  • 12. The embolic protection device according to claim 10, wherein the struts are radially spaced around the circumference of the conical geometry.
  • 13. The embolic protection device according to claim 10, wherein the filter portion includes a recess configured to trap emboli.
  • 14. The embolic protection device according to claim 13, wherein the recess has a generally conical geometry.
  • 15. An embolic protection device according to claim 10, wherein the pores are between about 80 and 100 micrometers.
  • 16. An embolic protection device for use in a vessel, the embolic protection device comprising: a filter portion including a porous foam body, the foam body having a generally conical geometry including a plurality of folds, each fold extending radially from an apex of the generally conical geometry and along a side of the generally conical geometry; anda plurality of struts attached to the filter portion and extending proximally therefrom, the filter portion and the plurality of struts forming a basket, where the basket is configured to have an expanded and collapsed state.
CROSS-REFERENCE TO RELATED APPLICATIONS

This application claims the benefit of U.S. Provisional Application Ser. No. 60/737,480 filed on Nov. 17, 2005, entitled “FOAM EMBOLIC PROTECTION DEVICE”, the entire contents of which are incorporated herein by reference.

US Referenced Citations (859)
Number Name Date Kind
3108593 Glassman Oct 1963 A
3334629 Cohn Aug 1967 A
3472230 Fogarty Oct 1969 A
3547103 Cook Dec 1970 A
3635223 Klieman Jan 1972 A
3923065 Nozick et al. Dec 1975 A
3952747 Kimmell, Jr. Apr 1976 A
3978863 Fettel et al. Sep 1976 A
3996938 Clark, III Dec 1976 A
4425908 Simon Jan 1984 A
4456000 Schjeldahl et al. Jun 1984 A
4494531 Gianturco Jan 1985 A
4548206 Osborne Oct 1985 A
4561439 Bishop et al. Dec 1985 A
4562039 Koehler Dec 1985 A
4604094 Shook Aug 1986 A
4619246 Molgaard-Nielsen et al. Oct 1986 A
4643184 Mobin-Uddin Feb 1987 A
4646736 Auth Mar 1987 A
4650472 Bates Mar 1987 A
4665906 Jervis May 1987 A
4669464 Sulepov Jun 1987 A
4688553 Metals Aug 1987 A
4723549 Wholey et al. Feb 1988 A
4727873 Mobin-Uddin Mar 1988 A
4732152 Wallsten et al. Mar 1988 A
4817600 Herms et al. Apr 1989 A
4824435 Giesy et al. Apr 1989 A
4832055 Palestrant May 1989 A
4846794 Hertzer Jul 1989 A
4848343 Wallsten et al. Jul 1989 A
4873978 Ginsburg Oct 1989 A
4943297 Saveliev et al. Jul 1990 A
4957501 Lahille et al. Sep 1990 A
4990156 Lefebvre Feb 1991 A
4998916 Hammerslag et al. Mar 1991 A
5053008 Bajaj Oct 1991 A
5059205 El-Nounou et al. Oct 1991 A
5069226 Yamauchi et al. Dec 1991 A
5078726 Kreamer Jan 1992 A
5100423 Fearnot Mar 1992 A
5108418 Lefebvre Apr 1992 A
5108419 Reger et al. Apr 1992 A
5112347 Taheri May 1992 A
5129890 Bates et al. Jul 1992 A
5133733 Rasmussen et al. Jul 1992 A
5147379 Sabbaghian et al. Sep 1992 A
5152777 Goldberg Oct 1992 A
5160342 Reger et al. Nov 1992 A
5163927 Woker et al. Nov 1992 A
5203772 Hammerslag et al. Apr 1993 A
5234458 Metais Aug 1993 A
5242462 El-Nounou Sep 1993 A
5243996 Hall Sep 1993 A
5251640 Osborne Oct 1993 A
5263964 Purdy Nov 1993 A
5300086 Gory et al. Apr 1994 A
5324304 Rasmussen Jun 1994 A
5329942 Gunther et al. Jul 1994 A
5344427 Cottenceau et al. Sep 1994 A
5350397 Palermo et al. Sep 1994 A
5350398 Pavcnik et al. Sep 1994 A
5364345 Lowery et al. Nov 1994 A
5370657 Irie Dec 1994 A
5375612 Cottenceau et al. Dec 1994 A
5383887 Nadal Jan 1995 A
5413586 Dibie et al. May 1995 A
5415630 Gory et al. May 1995 A
5417708 Hall et al. May 1995 A
5451233 Yock Sep 1995 A
5458573 Summers Oct 1995 A
5522881 Lentz Jun 1996 A
5527338 Purdy Jun 1996 A
5531788 Dibie et al. Jul 1996 A
5549551 Peacock et al. Aug 1996 A
5549626 Miller et al. Aug 1996 A
5556414 Turi Sep 1996 A
5562698 Parker Oct 1996 A
5571135 Fraser et al. Nov 1996 A
5591195 Taheri et al. Jan 1997 A
5601595 Smith Feb 1997 A
5624461 Mariant Apr 1997 A
5626605 Irie et al. May 1997 A
5630797 Diedrich et al. May 1997 A
5634942 Chevillon et al. Jun 1997 A
5649953 Lefebvre Jul 1997 A
5662703 Yurek et al. Sep 1997 A
5669933 Simon et al. Sep 1997 A
5681347 Cathcart et al. Oct 1997 A
5690642 Osborne et al. Nov 1997 A
5690667 Gia Nov 1997 A
5693067 Purdy Dec 1997 A
5693087 Parodi Dec 1997 A
5695518 Laerum Dec 1997 A
5695519 Summers et al. Dec 1997 A
5700253 Parker Dec 1997 A
5709704 Nott et al. Jan 1998 A
5713853 Clark et al. Feb 1998 A
5720764 Naderlinger Feb 1998 A
5725550 Nadal Mar 1998 A
5738667 Solar Apr 1998 A
5746767 Smith May 1998 A
5755772 Evans et al. May 1998 A
5755790 Chevillon et al. May 1998 A
5766203 Imran et al. Jun 1998 A
5769816 Barbut et al. Jun 1998 A
5769871 Mers et al. Jun 1998 A
5795322 Boudewijn Aug 1998 A
5800457 Gelbfish et al. Sep 1998 A
5800525 Bachinski et al. Sep 1998 A
5810874 Lefebvre Sep 1998 A
5814027 Hassett et al. Sep 1998 A
5814064 Daniel et al. Sep 1998 A
5820592 Hammerslag Oct 1998 A
5827324 Cassell et al. Oct 1998 A
5830230 Berryman et al. Nov 1998 A
5836968 Simon et al. Nov 1998 A
5836969 Kim et al. Nov 1998 A
5846260 Maahs Dec 1998 A
5853420 Chevillon et al. Dec 1998 A
5876367 Kaganov et al. Mar 1999 A
5893869 Barnhart et al. Apr 1999 A
5895391 Farnholtz Apr 1999 A
5895399 Barbut et al. Apr 1999 A
5895410 Forber et al. Apr 1999 A
5908435 Samuels Jun 1999 A
5910154 Tsugita et al. Jun 1999 A
5911702 Romley et al. Jun 1999 A
5911704 Humes Jun 1999 A
5911717 Jacobsen et al. Jun 1999 A
5911734 Tsugita et al. Jun 1999 A
5919224 Thompson et al. Jul 1999 A
5925062 Purdy Jul 1999 A
5925063 Khosravi Jul 1999 A
5928260 Chin et al. Jul 1999 A
5928261 Ruiz Jul 1999 A
5938683 Lefebvre Aug 1999 A
5941896 Kerr Aug 1999 A
5944728 Bates Aug 1999 A
5947985 Imran Sep 1999 A
5947995 Samuels Sep 1999 A
5948017 Taheri Sep 1999 A
5951567 Javier, Jr. et al. Sep 1999 A
5954741 Fox Sep 1999 A
5954742 Osypka Sep 1999 A
5954745 Gertler et al. Sep 1999 A
5968057 Taheri Oct 1999 A
5968071 Chevillon et al. Oct 1999 A
5972019 Engelson et al. Oct 1999 A
5976162 Doan et al. Nov 1999 A
5976172 Homsma et al. Nov 1999 A
5980555 Barbut et al. Nov 1999 A
5984947 Smith Nov 1999 A
5984965 Knapp et al. Nov 1999 A
5989281 Barbut et al. Nov 1999 A
6001118 Daniel et al. Dec 1999 A
6007557 Ambrisco et al. Dec 1999 A
6007558 Ravenscroft et al. Dec 1999 A
6010522 Barbut et al. Jan 2000 A
6013093 Nott et al. Jan 2000 A
6015424 Rosenbluth et al. Jan 2000 A
6027520 Tsugita et al. Feb 2000 A
6036717 Mers Kelly et al. Mar 2000 A
6036720 Abrams et al. Mar 2000 A
6042598 Tsugita et al. Mar 2000 A
6051014 Jang Apr 2000 A
6051015 Maahs Apr 2000 A
6053932 Daniel et al. Apr 2000 A
6059745 Gelbfish May 2000 A
6059813 Vrba et al. May 2000 A
6059814 Ladd May 2000 A
6063113 Kavteladze et al. May 2000 A
6066158 Engelson et al. May 2000 A
6068645 Tu May 2000 A
6074357 Kaganov et al. Jun 2000 A
6077274 Ouchi et al. Jun 2000 A
6080178 Meglin Jun 2000 A
6083239 Addis Jul 2000 A
6086577 Ken et al. Jul 2000 A
6086605 Barbut et al. Jul 2000 A
6093199 Brown et al. Jul 2000 A
6096053 Bates Aug 2000 A
6096070 Ragheb et al. Aug 2000 A
6099549 Bosma et al. Aug 2000 A
6106497 Wang Aug 2000 A
6126672 Berryman et al. Oct 2000 A
6126673 Kim et al. Oct 2000 A
6129739 Khosravi Oct 2000 A
6136016 Barbut et al. Oct 2000 A
6146396 Konya et al. Nov 2000 A
6146404 Kim et al. Nov 2000 A
6152931 Nadal et al. Nov 2000 A
6152946 Broome et al. Nov 2000 A
6152947 Ambrisco et al. Nov 2000 A
6156061 Wallace et al. Dec 2000 A
6156062 McGuinness Dec 2000 A
6159230 Samuels Dec 2000 A
6165179 Cathcart et al. Dec 2000 A
6165198 McGurk et al. Dec 2000 A
6165199 Barbut Dec 2000 A
6165200 Tsugita et al. Dec 2000 A
6168579 Tsugita et al. Jan 2001 B1
6168603 Leslie et al. Jan 2001 B1
6168610 Marin et al. Jan 2001 B1
6168622 Mazzocchi Jan 2001 B1
6171327 Daniel et al. Jan 2001 B1
6171328 Addis Jan 2001 B1
6174318 Bates et al. Jan 2001 B1
6179851 Barbut et al. Jan 2001 B1
6179859 Bates et al. Jan 2001 B1
6179860 Fulton, III et al. Jan 2001 B1
6179861 Khosravi et al. Jan 2001 B1
6187025 Machek Feb 2001 B1
6193739 Chevillon et al. Feb 2001 B1
6203561 Ramee et al. Mar 2001 B1
6206931 Cook et al. Mar 2001 B1
6214025 Thistle et al. Apr 2001 B1
6214026 Lepak et al. Apr 2001 B1
6221091 Khosravi Apr 2001 B1
6224620 Maahs May 2001 B1
6231588 Zadno-Azizi May 2001 B1
6231589 Wessman et al. May 2001 B1
6235044 Root et al. May 2001 B1
6235045 Barbut et al. May 2001 B1
6238412 Dubrul et al. May 2001 B1
6241746 Bosma et al. Jun 2001 B1
6245012 Kleshinski Jun 2001 B1
6245087 Addis Jun 2001 B1
6245088 Lowery Jun 2001 B1
6245089 Daniel et al. Jun 2001 B1
6251092 Qin et al. Jun 2001 B1
6251122 Tsukernik Jun 2001 B1
6254550 McNamara et al. Jul 2001 B1
6254633 Pinchuk et al. Jul 2001 B1
6258026 Ravenscroft et al. Jul 2001 B1
6258115 Dubrul Jul 2001 B1
6258120 McKenzie et al. Jul 2001 B1
6261305 Marotta et al. Jul 2001 B1
6264672 Fisher Jul 2001 B1
6267776 O'Connell Jul 2001 B1
6267777 Bosma et al. Jul 2001 B1
6273900 Nott et al. Aug 2001 B1
6273901 Whitcher et al. Aug 2001 B1
6277125 Barry et al. Aug 2001 B1
6277126 Barry et al. Aug 2001 B1
6277138 Levinson et al. Aug 2001 B1
6277139 Levinson et al. Aug 2001 B1
6280451 Bates et al. Aug 2001 B1
6287321 Jang Sep 2001 B1
6290710 Cryer et al. Sep 2001 B1
6299604 Ragheb et al. Oct 2001 B1
6306163 Fitz Oct 2001 B1
6309399 Barbut et al. Oct 2001 B1
6312444 Barbut Nov 2001 B1
6319268 Ambrisco et al. Nov 2001 B1
6325815 Kusleika et al. Dec 2001 B1
6325816 Fulton, III et al. Dec 2001 B1
6328755 Marshall Dec 2001 B1
6331183 Suon Dec 2001 B1
6331184 Abrams Dec 2001 B1
6334864 Amplatz et al. Jan 2002 B1
6336934 Gilson et al. Jan 2002 B1
6338739 Datta et al. Jan 2002 B1
6340364 Kanesaka Jan 2002 B2
6342062 Suon et al. Jan 2002 B1
6342063 DeVries et al. Jan 2002 B1
6344048 Chin et al. Feb 2002 B1
6344049 Levinson et al. Feb 2002 B1
6346116 Brooks et al. Feb 2002 B1
6348041 Klint Feb 2002 B1
6348063 Yassour et al. Feb 2002 B1
6350271 Kurz et al. Feb 2002 B1
6355051 Sisskind et al. Mar 2002 B1
6358228 Tubman et al. Mar 2002 B1
6361545 Macoviak et al. Mar 2002 B1
6361546 Khosravi Mar 2002 B1
6361547 Hieshima Mar 2002 B1
6364895 Greenhalgh Apr 2002 B1
6364896 Addis Apr 2002 B1
6368338 Konya et al. Apr 2002 B1
6371961 Osborne et al. Apr 2002 B1
6371969 Tsugita et al. Apr 2002 B1
6371970 Khosravi et al. Apr 2002 B1
6371971 Tsugita et al. Apr 2002 B1
6375670 Greenhalgh Apr 2002 B1
6379374 Hieshima et al. Apr 2002 B1
6380457 Yurek et al. Apr 2002 B1
6383146 Klint May 2002 B1
6383171 Gifford et al. May 2002 B1
6383174 Eder May 2002 B1
6383193 Cathcart et al. May 2002 B1
6383196 Leslie et al. May 2002 B1
6383205 Samson et al. May 2002 B1
6383206 Gillick et al. May 2002 B1
6391044 Yadav et al. May 2002 B1
6391045 Kim et al. May 2002 B1
6391052 Buirge et al. May 2002 B2
6395014 Macoviak et al. May 2002 B1
6402771 Palmer et al. Jun 2002 B1
6402772 Amplatz et al. Jun 2002 B1
6409742 Fulton, III et al. Jun 2002 B1
6413235 Parodi Jul 2002 B1
6416530 DeVries et al. Jul 2002 B2
6419686 McLeod et al. Jul 2002 B1
6423052 Escano Jul 2002 B1
6423086 Barbut et al. Jul 2002 B1
6425909 Dieck et al. Jul 2002 B1
6428557 Hilaire Aug 2002 B1
6428558 Jones et al. Aug 2002 B1
6428559 Johnson Aug 2002 B1
6432122 Gilson et al. Aug 2002 B1
6436112 Wensel et al. Aug 2002 B2
6436120 Meglin Aug 2002 B1
6436121 Blom Aug 2002 B1
6443926 Kletschka Sep 2002 B1
6443971 Boylan et al. Sep 2002 B1
6443972 Bosma et al. Sep 2002 B1
6443979 Stalker et al. Sep 2002 B1
6447530 Ostrovsky et al. Sep 2002 B1
6447531 Amplatz Sep 2002 B1
6454775 Demarais et al. Sep 2002 B1
6458139 Palmer et al. Oct 2002 B1
6458145 Ravenscroft et al. Oct 2002 B1
6461370 Gray et al. Oct 2002 B1
6468290 Weldon et al. Oct 2002 B1
6468291 Bates et al. Oct 2002 B2
6482222 Bruckheimer et al. Nov 2002 B1
6485456 Kletschka Nov 2002 B1
6485500 Kokish et al. Nov 2002 B1
6485501 Green Nov 2002 B1
6485502 Don Michael et al. Nov 2002 B2
6491712 O'Connor Dec 2002 B1
6494895 Addis Dec 2002 B2
6497709 Heath Dec 2002 B1
6499487 McKenzie et al. Dec 2002 B1
6500166 Zadno Azizi et al. Dec 2002 B1
6500191 Addis Dec 2002 B2
6502606 Klint Jan 2003 B2
6506203 Boyle et al. Jan 2003 B1
6506205 Goldberg et al. Jan 2003 B2
6508826 Murphy et al. Jan 2003 B2
6511492 Rosenbluth et al. Jan 2003 B1
6511496 Huter et al. Jan 2003 B1
6511497 Braun et al. Jan 2003 B1
6511503 Burkett et al. Jan 2003 B1
6514273 Voss et al. Feb 2003 B1
6517559 O'Connell Feb 2003 B1
6520978 Blackledge et al. Feb 2003 B1
6520983 Colgan et al. Feb 2003 B1
6527746 Oslund et al. Mar 2003 B1
6527791 Fisher Mar 2003 B2
6527962 Nadal Mar 2003 B1
6530935 Wensel et al. Mar 2003 B2
6530939 Hopkins et al. Mar 2003 B1
6530940 Fisher Mar 2003 B2
6533770 Lepulu et al. Mar 2003 B1
6533800 Barbut Mar 2003 B1
6537293 Berryman et al. Mar 2003 B1
6537294 Boyle et al. Mar 2003 B1
6537296 Levinson et al. Mar 2003 B2
6537297 Tsugita et al. Mar 2003 B2
6540722 Boyle et al. Apr 2003 B1
6540767 Walak et al. Apr 2003 B1
6540768 Diaz et al. Apr 2003 B1
6544221 Kokish et al. Apr 2003 B1
6544276 Azizi Apr 2003 B1
6544278 Vrba et al. Apr 2003 B1
6544279 Hopkins et al. Apr 2003 B1
6544280 Daniel et al. Apr 2003 B1
6547759 Fisher Apr 2003 B1
6551303 Van Tassel et al. Apr 2003 B1
6551341 Boylan et al. Apr 2003 B2
6551342 Shen et al. Apr 2003 B1
6554849 Jones et al. Apr 2003 B1
6558404 Tsukernik May 2003 B2
6558405 McInnes May 2003 B1
6558406 Okada May 2003 B2
6562058 Seguin et al. May 2003 B2
6565591 Brady et al. May 2003 B2
6569147 Evans et al. May 2003 B1
6569183 Kim et al. May 2003 B1
6569184 Huter May 2003 B2
6575995 Huter et al. Jun 2003 B1
6575996 Denison et al. Jun 2003 B1
6575997 Palmer et al. Jun 2003 B1
6579303 Amplatz Jun 2003 B2
6582396 Parodi Jun 2003 B1
6582447 Patel et al. Jun 2003 B1
6582448 Boyle et al. Jun 2003 B1
6589227 Klint Jul 2003 B2
6589230 Gia et al. Jul 2003 B2
6589263 Hopkins et al. Jul 2003 B1
6589264 Barbut et al. Jul 2003 B1
6589265 Palmer et al. Jul 2003 B1
6589266 Whitcher et al. Jul 2003 B2
6592546 Barbut et al. Jul 2003 B1
6592606 Huter et al. Jul 2003 B2
6592616 Stack et al. Jul 2003 B1
6595983 Voda Jul 2003 B2
6596011 Johnson et al. Jul 2003 B2
6599275 Fischer, Jr. Jul 2003 B1
6599307 Huter et al. Jul 2003 B1
6599308 Amplatz Jul 2003 B2
6602271 Adams et al. Aug 2003 B2
6602273 Marshall Aug 2003 B2
6602280 Chobotov Aug 2003 B2
6605102 Mazzocchi et al. Aug 2003 B1
6607506 Kletschka Aug 2003 B2
6610077 Hancock et al. Aug 2003 B1
6611720 Hata et al. Aug 2003 B2
6613074 Mitelberg et al. Sep 2003 B1
6616679 Khosravi et al. Sep 2003 B1
6616680 Thielen Sep 2003 B1
6616681 Hanson et al. Sep 2003 B2
6616682 Joergensen et al. Sep 2003 B2
6620148 Tsugita Sep 2003 B1
6620182 Khosravi et al. Sep 2003 B1
6623450 Dutta Sep 2003 B1
6623506 McGuckin, Jr. et al. Sep 2003 B2
6629953 Boyd Oct 2003 B1
6635068 Dubrul et al. Oct 2003 B1
6635069 Teoh et al. Oct 2003 B1
6635070 Evans et al. Oct 2003 B2
6638293 Makower et al. Oct 2003 B1
6638294 Palmer Oct 2003 B1
6638372 Abrams et al. Oct 2003 B1
6641590 Palmer et al. Nov 2003 B1
6641605 Stergiopulos Nov 2003 B1
6645160 Heesch Nov 2003 B1
6645220 Huter et al. Nov 2003 B1
6645221 Richter Nov 2003 B1
6645222 Parodi et al. Nov 2003 B1
6645223 Boyle et al. Nov 2003 B2
6645224 Gilson et al. Nov 2003 B2
6652554 Wholey et al. Nov 2003 B1
6652557 MacDonald Nov 2003 B1
6652558 Patel et al. Nov 2003 B2
6656201 Ferrera et al. Dec 2003 B2
6656202 Papp et al. Dec 2003 B2
6656203 Roth et al. Dec 2003 B2
6656204 Ambrisco et al. Dec 2003 B2
6656351 Boyle Dec 2003 B2
6660021 Palmer et al. Dec 2003 B1
6663613 Evans et al. Dec 2003 B1
6663650 Sepetka et al. Dec 2003 B2
6663651 Krolik et al. Dec 2003 B2
6663652 Daniel et al. Dec 2003 B2
6676682 Tsugita et al. Jan 2004 B1
6679902 Boyle et al. Jan 2004 B1
6689144 Gerberding Feb 2004 B2
6695813 Boyle et al. Feb 2004 B1
6695865 Boyle et al. Feb 2004 B2
6702834 Boylan et al. Mar 2004 B1
6709450 Kang et al. Mar 2004 B2
6712835 Mazzocchi et al. Mar 2004 B2
6716207 Farnholtz Apr 2004 B2
6716231 Rafiee et al. Apr 2004 B1
6726701 Gilson et al. Apr 2004 B2
6730064 Ragheb et al. May 2004 B2
6755856 Fierens et al. Jun 2004 B2
6758855 Fulton, III et al. Jul 2004 B2
6761727 Ladd Jul 2004 B1
6773446 Dwyer et al. Aug 2004 B1
6773448 Kusleika et al. Aug 2004 B2
6774278 Ragheb et al. Aug 2004 B1
6780175 Sachdeva et al. Aug 2004 B1
6793667 Hebert et al. Sep 2004 B2
6793668 Fisher Sep 2004 B1
6833002 Stack et al. Dec 2004 B2
6855154 Abdel-Gawwad Feb 2005 B2
6866677 Douk et al. Mar 2005 B2
6866680 Yassour et al. Mar 2005 B2
6872211 White et al. Mar 2005 B2
6878153 Linder et al. Apr 2005 B2
6896691 Boylan et al. May 2005 B2
6929709 Smith Aug 2005 B2
6932831 Forber Aug 2005 B2
6939361 Kleshinski Sep 2005 B1
6942682 Vrba et al. Sep 2005 B2
6955685 Escamilla et al. Oct 2005 B2
6964670 Shah et al. Nov 2005 B1
6964674 Matsuura et al. Nov 2005 B1
6969396 Krolik et al. Nov 2005 B2
6974469 Broome et al. Dec 2005 B2
6974473 Barclay et al. Dec 2005 B2
6986784 Weiser et al. Jan 2006 B1
6991641 Diaz et al. Jan 2006 B2
7128073 Van Der Burg et al. Oct 2006 B1
7166120 Kusleika Jan 2007 B2
7174636 Lowe Feb 2007 B2
7189249 Hart et al. Mar 2007 B2
7255687 Huang et al. Aug 2007 B2
7285130 Austin Oct 2007 B2
7306619 Palmer Dec 2007 B1
7371248 Dapolito et al. May 2008 B2
7393358 Malewicz Jul 2008 B2
7604649 McGuckin et al. Oct 2009 B2
7666216 Hogendijk et al. Feb 2010 B2
7731722 Lavelle et al. Jun 2010 B2
7766934 Pal et al. Aug 2010 B2
20010000799 Wessman et al. May 2001 A1
20010001817 Humes May 2001 A1
20010005789 Root et al. Jun 2001 A1
20010007947 Kanesaka Jul 2001 A1
20010011181 DiMatteo Aug 2001 A1
20010011182 Dubrul et al. Aug 2001 A1
20010012951 Bates et al. Aug 2001 A1
20010016755 Addis Aug 2001 A1
20010020175 Yassour et al. Sep 2001 A1
20010023358 Tsukernik Sep 2001 A1
20010025187 Okada Sep 2001 A1
20010031980 Wensel et al. Oct 2001 A1
20010031981 Evans et al. Oct 2001 A1
20010031982 Peterson et al. Oct 2001 A1
20010039431 DeVries et al. Nov 2001 A1
20010039432 Whitcher et al. Nov 2001 A1
20010041908 Levinson et al. Nov 2001 A1
20010041909 Tsugita et al. Nov 2001 A1
20010041928 Pavcnik et al. Nov 2001 A1
20010044632 Daniel et al. Nov 2001 A1
20010044634 Don Michael et al. Nov 2001 A1
20010053921 Jang Dec 2001 A1
20020002383 Sepetka et al. Jan 2002 A1
20020002384 Gilson et al. Jan 2002 A1
20020004667 Adams et al. Jan 2002 A1
20020016564 Courtney et al. Feb 2002 A1
20020016609 Wensel et al. Feb 2002 A1
20020022858 Demond et al. Feb 2002 A1
20020022859 Hogendijk Feb 2002 A1
20020026211 Khosravi et al. Feb 2002 A1
20020026212 Wholey et al. Feb 2002 A1
20020026213 Gilson et al. Feb 2002 A1
20020032460 Kusleika et al. Mar 2002 A1
20020032461 Marshall Mar 2002 A1
20020042626 Hanson et al. Apr 2002 A1
20020042627 Brady et al. Apr 2002 A1
20020045915 Balceta et al. Apr 2002 A1
20020045916 Gray et al. Apr 2002 A1
20020045918 Suon et al. Apr 2002 A1
20020049452 Kurz et al. Apr 2002 A1
20020049468 Streeter et al. Apr 2002 A1
20020052627 Boylan et al. May 2002 A1
20020058904 Boock et al. May 2002 A1
20020058911 Gilson et al. May 2002 A1
20020058963 Vale et al. May 2002 A1
20020058964 Addis May 2002 A1
20020062133 Gilson et al. May 2002 A1
20020062134 Barbut et al. May 2002 A1
20020062135 Mazzocchi et al. May 2002 A1
20020065507 Zadno-Azizi May 2002 A1
20020068954 Foster Jun 2002 A1
20020068955 Khosravi Jun 2002 A1
20020072764 Sepetka et al. Jun 2002 A1
20020072765 Mazzocchi et al. Jun 2002 A1
20020077596 McKenzie et al. Jun 2002 A1
20020082558 Samson et al. Jun 2002 A1
20020082639 Broome et al. Jun 2002 A1
20020087187 Mazzocchi et al. Jul 2002 A1
20020090389 Humes et al. Jul 2002 A1
20020091407 Zadno-Azizi et al. Jul 2002 A1
20020091408 Sutton et al. Jul 2002 A1
20020091409 Sutton et al. Jul 2002 A1
20020095170 Krolik et al. Jul 2002 A1
20020095171 Belef Jul 2002 A1
20020095172 Mazzocchi et al. Jul 2002 A1
20020095173 Mazzocchi et al. Jul 2002 A1
20020095174 Tsugita et al. Jul 2002 A1
20020099405 Yurek et al. Jul 2002 A1
20020099407 Becker et al. Jul 2002 A1
20020099435 Stinson Jul 2002 A1
20020103501 Diaz et al. Aug 2002 A1
20020107541 Vale et al. Aug 2002 A1
20020111647 Khairkhahan et al. Aug 2002 A1
20020111648 Kusleika et al. Aug 2002 A1
20020111649 Russo et al. Aug 2002 A1
20020116024 Goldberg et al. Aug 2002 A1
20020120226 Beck Aug 2002 A1
20020120286 DoBrava et al. Aug 2002 A1
20020120287 Huter Aug 2002 A1
20020123720 Kusleika et al. Sep 2002 A1
20020123755 Lowe et al. Sep 2002 A1
20020123759 Amplatz Sep 2002 A1
20020123766 Seguin et al. Sep 2002 A1
20020128679 Turovskiy et al. Sep 2002 A1
20020128680 Pavlovic Sep 2002 A1
20020128681 Broome et al. Sep 2002 A1
20020133191 Khosravi et al. Sep 2002 A1
20020133192 Kusleika et al. Sep 2002 A1
20020138094 Borillo et al. Sep 2002 A1
20020138095 Mazzocchi et al. Sep 2002 A1
20020138096 Hieshima Sep 2002 A1
20020138097 Ostrovsky et al. Sep 2002 A1
20020143360 Douk et al. Oct 2002 A1
20020143361 Douk et al. Oct 2002 A1
20020143362 Macoviak et al. Oct 2002 A1
20020151927 Douk et al. Oct 2002 A1
20020151928 Leslie et al. Oct 2002 A1
20020156520 Boylan et al. Oct 2002 A1
20020161389 Boyle et al. Oct 2002 A1
20020161390 Mouw Oct 2002 A1
20020161391 Murphy et al. Oct 2002 A1
20020161392 Dubrul Oct 2002 A1
20020161393 Demond et al. Oct 2002 A1
20020161394 Macoviak et al. Oct 2002 A1
20020161395 Douk et al. Oct 2002 A1
20020161396 Jang et al. Oct 2002 A1
20020165557 McAlister Nov 2002 A1
20020165573 Barbut Nov 2002 A1
20020165576 Boyle et al. Nov 2002 A1
20020165598 Wahr et al. Nov 2002 A1
20020169472 Douk et al. Nov 2002 A1
20020169474 Kusleika et al. Nov 2002 A1
20020173815 Hogendijk et al. Nov 2002 A1
20020173819 Leeflang et al. Nov 2002 A1
20020177872 Papp et al. Nov 2002 A1
20020177899 Eum et al. Nov 2002 A1
20020183781 Casey et al. Dec 2002 A1
20020183782 Tsugita et al. Dec 2002 A1
20020183783 Shadduck Dec 2002 A1
20020188313 Johnson et al. Dec 2002 A1
20020188314 Anderson et al. Dec 2002 A1
20020193824 Boylan et al. Dec 2002 A1
20020193825 McGuckin et al. Dec 2002 A1
20020193826 McGuckin et al. Dec 2002 A1
20020193827 McGuckin et al. Dec 2002 A1
20020193828 Griffin et al. Dec 2002 A1
20020198561 Amplatz Dec 2002 A1
20030004536 Boylan et al. Jan 2003 A1
20030004537 Boyle et al. Jan 2003 A1
20030004538 Secrest et al. Jan 2003 A1
20030004539 Linder et al. Jan 2003 A1
20030004540 Linder et al. Jan 2003 A1
20030004542 Wensel et al. Jan 2003 A1
20030009146 Muni et al. Jan 2003 A1
20030009189 Gilson et al. Jan 2003 A1
20030009190 Kletschka et al. Jan 2003 A1
20030009191 Wensel et al. Jan 2003 A1
20030014072 Wensel et al. Jan 2003 A1
20030018354 Roth et al. Jan 2003 A1
20030018355 Goto et al. Jan 2003 A1
20030023263 Krolik et al. Jan 2003 A1
20030023264 Dieck et al. Jan 2003 A1
20030023265 Forber Jan 2003 A1
20030032976 Boucek Feb 2003 A1
20030032977 Brady Feb 2003 A1
20030040772 Hyodoh et al. Feb 2003 A1
20030045897 Huter et al. Mar 2003 A1
20030045898 Harrison et al. Mar 2003 A1
20030050662 Don Michael Mar 2003 A1
20030055452 Joergensen et al. Mar 2003 A1
20030055480 Fischell et al. Mar 2003 A1
20030060843 Boucher Mar 2003 A1
20030060844 Borillo et al. Mar 2003 A1
20030065354 Boyle et al. Apr 2003 A1
20030065355 Weber Apr 2003 A1
20030065356 Tsugita et al. Apr 2003 A1
20030069596 Eskuri Apr 2003 A1
20030073979 Naimark et al. Apr 2003 A1
20030074019 Gray et al. Apr 2003 A1
20030074054 Duerig et al. Apr 2003 A1
20030078614 Salahieh et al. Apr 2003 A1
20030083608 Evans et al. May 2003 A1
20030083692 Vrba et al. May 2003 A1
20030083693 Daniel et al. May 2003 A1
20030088211 Anderson et al. May 2003 A1
20030088266 Bowlin May 2003 A1
20030093110 Vale May 2003 A1
20030093112 Addis May 2003 A1
20030097094 Ouriel et al. May 2003 A1
20030097145 Goldberg et al. May 2003 A1
20030100917 Boyle et al. May 2003 A1
20030100918 Duane May 2003 A1
20030100919 Hopkins et al. May 2003 A1
20030105472 McAlister Jun 2003 A1
20030105484 Boyle et al. Jun 2003 A1
20030105486 Murphy et al. Jun 2003 A1
20030109824 Anderson et al. Jun 2003 A1
20030109897 Walak et al. Jun 2003 A1
20030109916 Don Michael Jun 2003 A1
20030114879 Euteneuer et al. Jun 2003 A1
20030114880 Hansen et al. Jun 2003 A1
20030120303 Boyle et al. Jun 2003 A1
20030120304 Kaganov et al. Jun 2003 A1
20030125764 Brady et al. Jul 2003 A1
20030125765 Blackledge et al. Jul 2003 A1
20030130680 Russell Jul 2003 A1
20030130681 Ungs Jul 2003 A1
20030130682 Broome et al. Jul 2003 A1
20030130684 Brady et al. Jul 2003 A1
20030130685 Daniel et al. Jul 2003 A1
20030130686 Daniel et al. Jul 2003 A1
20030130687 Daniel et al. Jul 2003 A1
20030130688 Daniel et al. Jul 2003 A1
20030135232 Douk et al. Jul 2003 A1
20030135233 Bates et al. Jul 2003 A1
20030139764 Levinson et al. Jul 2003 A1
20030139765 Patel et al. Jul 2003 A1
20030144685 Boyle et al. Jul 2003 A1
20030144686 Martinez et al. Jul 2003 A1
20030144687 Brady et al. Jul 2003 A1
20030144688 Brady et al. Jul 2003 A1
20030144689 Brady et al. Jul 2003 A1
20030150821 Bates et al. Aug 2003 A1
20030153935 Mialhe Aug 2003 A1
20030153942 Wang et al. Aug 2003 A1
20030153943 Michael et al. Aug 2003 A1
20030153944 Phung et al. Aug 2003 A1
20030153945 Patel et al. Aug 2003 A1
20030158518 Schonholz et al. Aug 2003 A1
20030158574 Esch et al. Aug 2003 A1
20030158575 Boylan et al. Aug 2003 A1
20030163158 White Aug 2003 A1
20030163159 Patel et al. Aug 2003 A1
20030167068 Amplatz Sep 2003 A1
20030167069 Gonzales et al. Sep 2003 A1
20030171769 Barbut Sep 2003 A1
20030171770 Kusleika et al. Sep 2003 A1
20030171771 Anderson et al. Sep 2003 A1
20030171772 Amplatz Sep 2003 A1
20030171800 Bicek et al. Sep 2003 A1
20030171803 Shimon Sep 2003 A1
20030176884 Berrada et al. Sep 2003 A1
20030176885 Broome et al. Sep 2003 A1
20030176886 Wholey et al. Sep 2003 A1
20030176887 Petersen Sep 2003 A1
20030176888 O'Connell Sep 2003 A1
20030176889 Boyle et al. Sep 2003 A1
20030181942 Sutton et al. Sep 2003 A1
20030181943 Daniel et al. Sep 2003 A1
20030717769 Barbut Sep 2003
20030187474 Keegan et al. Oct 2003 A1
20030187475 Tsugita et al. Oct 2003 A1
20030187495 Cully et al. Oct 2003 A1
20030191492 Gellman et al. Oct 2003 A1
20030191493 Epstein et al. Oct 2003 A1
20030195554 Shen et al. Oct 2003 A1
20030195555 Khairkhahan et al. Oct 2003 A1
20030195556 Stack et al. Oct 2003 A1
20030199819 Beck Oct 2003 A1
20030199917 Knudson et al. Oct 2003 A1
20030199918 Patel et al. Oct 2003 A1
20030199919 Palmer et al. Oct 2003 A1
20030199920 Boylan et al. Oct 2003 A1
20030199921 Palmer et al. Oct 2003 A1
20030204168 Bosma et al. Oct 2003 A1
20030204202 Palmer et al. Oct 2003 A1
20030204203 Khairkhahan et al. Oct 2003 A1
20030208222 Zadno-Azizi Nov 2003 A1
20030208224 Broome Nov 2003 A1
20030208225 Goll et al. Nov 2003 A1
20030208226 Bruckheimer et al. Nov 2003 A1
20030208227 Thomas Nov 2003 A1
20030208228 Gilson et al. Nov 2003 A1
20030208229 Kletschka Nov 2003 A1
20030208253 Beyer et al. Nov 2003 A1
20030212428 Richter Nov 2003 A1
20030212429 Keegan et al. Nov 2003 A1
20030212431 Brady et al. Nov 2003 A1
20030212432 Khairkhahan et al. Nov 2003 A1
20030212433 Ambrisco et al. Nov 2003 A1
20030212434 Thielen Nov 2003 A1
20030216774 Larson Nov 2003 A1
20030220665 Eskuri et al. Nov 2003 A1
20030220667 Van der Burg et al. Nov 2003 A1
20030225418 Esksuri et al. Dec 2003 A1
20030225435 Huter et al. Dec 2003 A1
20030229374 Brady et al. Dec 2003 A1
20030233117 Adams et al. Dec 2003 A1
20040006364 Ladd Jan 2004 A1
20040006365 Brady et al. Jan 2004 A1
20040006370 Tsugita Jan 2004 A1
20040015152 Day Jan 2004 A1
20040039412 Isshiki et al. Feb 2004 A1
20040225321 Krolik et al. Feb 2004 A1
20040049226 Keegan et al. Mar 2004 A1
20040054394 Lee Mar 2004 A1
20040054395 Lee et al. Mar 2004 A1
20040059372 Tsugita Mar 2004 A1
20040064067 Ward Apr 2004 A1
20040064179 Linder et al. Apr 2004 A1
20040068271 McAlister Apr 2004 A1
20040078044 Kear Apr 2004 A1
20040082962 Demarais et al. Apr 2004 A1
20040088038 Dehnad et al. May 2004 A1
20040093009 Denison et al. May 2004 A1
20040093012 Cully et al. May 2004 A1
20040093016 Root et al. May 2004 A1
20040093059 Lee et al. May 2004 A1
20040098022 Barone May 2004 A1
20040098026 Joergensen et al. May 2004 A1
20040098033 Leeflang et al. May 2004 A1
20040098112 DiMatteo et al. May 2004 A1
20040102719 Keith et al. May 2004 A1
20040106944 Daniel et al. Jun 2004 A1
20040116831 Vrba Jun 2004 A1
20040133232 Rosenbluth et al. Jul 2004 A1
20040138696 Drasler et al. Jul 2004 A1
20040153118 Clubb et al. Aug 2004 A1
20040158278 Becker et al. Aug 2004 A1
20040162576 Barbut et al. Aug 2004 A1
20040164030 Lowe et al. Aug 2004 A1
20040167567 Cano et al. Aug 2004 A1
20040176794 Khosravi Sep 2004 A1
20040176833 Pavcnik et al. Sep 2004 A1
20040199203 Oslund et al. Oct 2004 A1
20040204737 Boismier et al. Oct 2004 A1
20040215322 Kerr Oct 2004 A1
20040236369 Dubrul Nov 2004 A1
20050004663 Llanos et al. Jan 2005 A1
20050021125 Stack et al. Jan 2005 A1
20050027345 Horan et al. Feb 2005 A1
20050038468 Panetta et al. Feb 2005 A1
20050038503 Greenhaigh Feb 2005 A1
20050043743 Dennis Feb 2005 A1
20050043756 Lavelle et al. Feb 2005 A1
20050043780 Gifford et al. Feb 2005 A1
20050049668 Jones et al. Mar 2005 A1
20050126979 Lowe et al. Jun 2005 A1
20050137696 Salahieh et al. Jun 2005 A1
20050149110 Wholey et al. Jul 2005 A1
20050165480 Jordan et al. Jul 2005 A1
20050177186 Cully et al. Aug 2005 A1
20050177246 Datta et al. Aug 2005 A1
20050197688 Theron et al. Sep 2005 A1
20050209634 Brady et al. Sep 2005 A1
20050216053 Douk et al. Sep 2005 A1
20050217767 Barvosa-Carter et al. Oct 2005 A1
20050228474 Laguna Oct 2005 A1
20060009798 Callister et al. Jan 2006 A1
20060009799 Kleshinski et al. Jan 2006 A1
20060020334 Lashinski et al. Jan 2006 A1
20060030923 Gunderson Feb 2006 A1
20060074474 Theron Apr 2006 A1
20060100544 Ayala et al. May 2006 A1
20060100545 Ayala et al. May 2006 A1
20060161241 Barbut et al. Jul 2006 A1
20060184194 Pal et al. Aug 2006 A1
20060200221 Malewicz Sep 2006 A1
20060229660 Pal et al. Oct 2006 A1
20060264707 Kinney Nov 2006 A1
20060287668 Fawzi et al. Dec 2006 A1
20070038241 Pal Feb 2007 A1
20070100372 Schaeffer May 2007 A1
20070112374 Paul, Jr. et al. May 2007 A1
20070129752 Webler et al. Jun 2007 A1
20070149996 Coughlin Jun 2007 A1
20070167974 Cully et al. Jul 2007 A1
20070185521 Bui et al. Aug 2007 A1
20070250108 Boyle et al. Oct 2007 A1
20070288054 Tanaka et al. Dec 2007 A1
20080015518 Huang et al. Jan 2008 A1
20080027481 Gilson et al. Jan 2008 A1
20080103522 Steingisser et al. May 2008 A1
20080154236 Elkins et al. Jun 2008 A1
20080167629 Dann et al. Jul 2008 A1
20080255587 Cully et al. Oct 2008 A1
20080255606 Mitra et al. Oct 2008 A1
20080262337 Falwell et al. Oct 2008 A1
20080275569 Lesh Nov 2008 A1
Foreign Referenced Citations (13)
Number Date Country
3429850 Feb 1986 DE
1127556 Aug 2001 EP
1310219 May 2003 EP
1516601 Mar 2005 EP
1557137 Jul 2005 EP
WO 9203097 Mar 1992 WO
WO 9610591 Apr 1996 WO
WO 9916382 Apr 1999 WO
WO 9923976 May 1999 WO
WO 9944510 Sep 1999 WO
WO 0182831 Nov 2001 WO
WO 03077799 Sep 2003 WO
WO 2006138391 Dec 2006 WO
Related Publications (1)
Number Date Country
20070118173 A1 May 2007 US
Provisional Applications (1)
Number Date Country
60737480 Nov 2005 US